This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Greenberg: Taking the Scalpel to Intuitive Surgical

SAN DIEGO (TheStreet) -- Easy come, easy go. So goes the story of Intuitive Surgical (ISRG - Get Report), whose shares leapt higher Jan. 14 after the company issued sharply higher fourth-quarter guidance.

Actual headline results, reported Thursday, were in line with expectations but...the trouble, which has caused the stock to slump, was below the headlines.

Notably, the gross margin on product sales tumbled to 69.5% from 73% a year earlier. At the same time, inventories skyrocketed -- not a good combo. CFO Marshall Mohr blamed the lower margin on "expensing certain system production costs in light of lower system unit production."

Equally troubling, procedures are expected to "stabilize" in 2014, growing 9% to 12% but down from 16% in 2013.

Must Read: Greenberg: Moral of the Herbalife Story*

Stabilizing or not, the company then lowered the boom: "Due to lack of visibility," it's not providing revenue guidance this year.

Reality: I'm not a fan of guidance, in general, but when a company withdraws it because it has no "visibility," it is never a good sign. (Yet another reason guidance is silly.) Intuitive's candor is admirable and noteworthy; at least its management isn't trying to bluff. It knows it faces a number of challenges related to health care costs and (while it doesn't come out and say it) growing concerns regarding the overuse of its da Vinci. I lay out much of this in my CNBC documentary The da Vinci Debate. Until this is hashed out, Intuitive's reset continues. Robotic surgery isn't going away; to the contrary. But its hyper-growth days are likely over.

Correction: An earlier version of this story incorrectly said that the company's gross margin on product sales tumbled to 61% from 73% a year earlier.

-- Written by Herb Greenberg in San Diego



Herb Greenberg, editor of Herb Greenberg's Reality Check, is a contributor to CNBC. He does not own shares, short or trade shares in an individual corporate security.

Markets

Chart of I:DJI
DOW 17,550.69 -47.51 -0.27%
S&P 500 2,093.32 -4.72 -0.22%
NASDAQ 5,105.5460 -9.8360 -0.19%

Herb's Tweets

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs